<?xml version="1.0" encoding="UTF-8"?>
<p id="para0012">The immune dysregulation seen in CRS and sHLH/MAS has recently been described in some patients with severe COVID-19 and overlaps with IRIS (
 <xref rid="fig0001" ref-type="fig">Figure 1</xref> and 
 <xref rid="tbl0001" ref-type="table">Table 1</xref>); therefore, applying lessons learned from the cell therapy literature may provide important insights into severity classification and prognostic clues 
 <xref rid="bib0017" ref-type="bibr">[17]</xref>.
</p>
